Achieving CD8+ T cell-dependent lethality by targeting cancer USP14 in hepatocellular carcinoma

作者
Binkui Li,Yichuan Yuan,Yi Niu,Zhenkun Huang,Yunxing Shi,Lin Zhu,Dinglan Zuo,Chengrui Zhong,Kai Li,Yunfei Yuan,Xin‐Yuan Guan
出处
期刊:Research Square
标识
DOI:10.21203/rs.3.rs-1826984/v2
摘要

Abstract Background & aims: The application of immunotherapy in hepatocellular carcinoma has been hindered by resistance to therapeutics. Cancer cell-induced CD8+ T cell malfunction may account for the failure of tumor immunotherapies. The crucial regulators in HCC that mediate resistance to CD8+ T cell-based cancer immunotherapy are still obscure. Methods: Three independent CRISPR genome-wide screening was constructed. HCC cell-CD8+T cell co-culture model and mouse HCC models were performed to explore the effect of cancer USP14 in vitro and in vivo . Metabolomics, glucose up-take analysis and immune co-precipitation were performed for mechanismstudy. scRNA-seq, HCC PDO and PDX models were used to validate the therapeutic potential of targeting cancer USP14. Results: USP14 was identified as an essential driver of HCC cells tolerating to CD8+ T cells. Cancer USP14 was upregulated and positively correlated with resistance to anti-PD1 therapy and poor prognoses in HCC patients. Inhibition of cancer USP14 reduced the growth of HCC cell with CD8+ T cell co-culturing and enhanced the function of co-cultured CD8+ T cells. Targeting cancer USP14 inhibited HCC tumor growth and boosted anti-PD1-induced tumor immunity in vivo. USP14 highly-expressed HCC cells were avidly consumed and outcompeted CD8+ T cells for glucose by stabilizing GLUT1, resulting in CD8+ T cells starving and malfunction. These HCC cells also lead to acidification in the TME, causing CD8+ T cell dysfunction. The PDO and PDX models confirmed the above results. Conclusions: Our data defined a pro-immunoevasiverole for cancer USP14 in CD8+ T cell-based tumor immunity. Combining USP14 inhibition and PD1 blockade constitutes a potential therapy for HCC. Lay summary: Cancer USP14 sever as a potential therapeutic target for HCC.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
汝坤完成签到 ,获得积分10
1秒前
1秒前
2秒前
2秒前
2秒前
英姑的应助被lydia采纳,获得10
3秒前
molihuakai的应助被吱吱采纳,获得10
3秒前
学术蝗虫发布了新的文献求助10
4秒前
4秒前
4秒前
xxxxx发布了新的文献求助10
6秒前
6秒前
我写不会这个研究报告完成签到,获得积分10
6秒前
lcj1014发布了新的文献求助10
6秒前
共享精神的应助被sxnyyy采纳,获得10
7秒前
7秒前
向晚彭彭发布了新的文献求助10
7秒前
7秒前
7秒前
李渠发布了新的文献求助10
8秒前
一颗苹果的应助被风清扬采纳,获得10
8秒前
9秒前
9秒前
苏小满发布了新的文献求助10
9秒前
学医没出路完成签到 ,获得积分10
10秒前
雨如是发布了新的文献求助10
10秒前
enchanterlv发布了新的文献求助30
10秒前
wm发布了新的文献求助10
11秒前
stone完成签到 ,获得积分10
11秒前
小蜗完成签到,获得积分10
11秒前
11秒前
12秒前
淡淡的凤完成签到,获得积分10
12秒前
SciGPT的应助被FZ采纳,获得10
12秒前
wwt发布了新的文献求助10
12秒前
sean发布了新的文献求助10
13秒前
13秒前
徐锦怡发布了新的文献求助10
13秒前
14秒前
ZZZ发布了新的文献求助10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183880
求助须知:如何正确求助?哪些是违规求助? 9573054
关于积分的说明 21828982
捐赠科研通 7780959
什么是DOI,文献DOI怎么找? 3434134
关于科研通互助平台的介绍 2558315
邀请新用户注册赠送积分活动 2480634